Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,916 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reversible Transition between Discrete and 1D Infinite Architectures: A Temperature-Responsive Cu(I) Complex with a Flexible Disilane-Bridged Bis(pyridine) Ligand.
Zhao Y, Nakae T, Takeya S, Hattori M, Saito D, Kato M, Ohmasa Y, Sato S, Yamamuro O, Galica T, Nishibori E, Kobayashi S, Seki T, Yamada T, Yamanoi Y. Zhao Y, et al. Among authors: sato s. Chemistry. 2023 Jul 6;29(38):e202204002. doi: 10.1002/chem.202204002. Epub 2023 May 15. Chemistry. 2023. PMID: 37084044
Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
Bekki T, Shimomura M, Yano T, Akabane S, Hattori M, Mochizuki T, Ono K, Matsubara K, Imaoka K, Ishikawa S, Watanabe A, Sato S, Ohdan H. Bekki T, et al. Among authors: sato s. Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300-1. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38679678 No abstract available.
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.
Sato S, Ssuzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Kunisaki C, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H. Sato S, et al. Int J Clin Oncol. 2024 Apr 28. doi: 10.1007/s10147-024-02532-0. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38679627
Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society.
Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, Terai H, Tanaka K, Sato S, Hagiwara E, Takei R, Kondoh Y, Takazono T, Hashimoto M, Tasaka S, Ohrui T, Tanino Y, Mineshita M, Komase Y, Miyazaki K, Nishikawa M, Ando A, Kita H, Ichihara E, Ohshimo S, Murata Y, Ishida M, Kobayashi S, Uchida T, Tateno H, Ikari J, Terashima T, Kozu Y, Tateishi T, Shinkai M, Sagara H, To Y, Ito Y, Yamamoto M, Yamamoto Y, Kita T, Ito Y, Tomii K, Fujita Y, Funaki Y, Yatera K, Yamasue M, Komiya K, Kozawa S, Manabe H, Hozumi H, Horiguchi T, Kitajima T, Nakano Y, Nagaoka T, Hojo M, Ebihara A, Kobayashi M, Takayama K, Jinta T, Sawai T, Fukuda Y, Kaneko T, Chin K, Ogura T, Mukae H, Ishii M, Yokoyama A. Kamata H, et al. Among authors: sato s. Respir Investig. 2024 Apr 25;62(4):572-579. doi: 10.1016/j.resinv.2024.02.009. Online ahead of print. Respir Investig. 2024. PMID: 38669898
Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease.
Yamakawa H, Sato S, Ohta H, Kusano K, Kawabe R, Oba T, Uzuka C, Sasaki H, Akasaka K, Amano M, Takemura T, Araya J, Matsushima H. Yamakawa H, et al. Among authors: sato s. Respir Investig. 2024 Apr 24;62(4):551-557. doi: 10.1016/j.resinv.2024.04.011. Online ahead of print. Respir Investig. 2024. PMID: 38663299
11,916 results
You have reached the last available page of results. Please see the User Guide for more information.